Device
Aurix
Total Trials
4
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Active Trials
0(0%)
Phase Distribution
Ph phase_4
1
25%
Ph not_applicable
3
75%
Phase Distribution
0
Early Stage
0
Mid Stage
1
Late Stage
Phase Distribution4 total trials
Phase 4Post-market surveillance
1(25.0%)
N/ANon-phased studies
3(75.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
0.0%
0 of 1 finished
Non-Completion Rate
100.0%
1 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Terminated(1)
Other(3)
Detailed Status
unknown3
Withdrawn1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
N/A
Most Advanced
Phase 4
Trials by Phase
Phase 41 (25.0%)
N/A3 (75.0%)
Trials by Status
unknown375%
withdrawn125%
Recent Activity
0 active trials
Showing 4 of 4
unknownnot_applicable
Effectiveness of Aurix Therapy in Venous Leg Ulcers
NCT02352454
unknownnot_applicable
Effectiveness of Aurix Therapy in Pressure Ulcers
NCT02352467
unknownnot_applicable
Effectiveness of Aurix Therapy in Diabetic Foot Ulcers
NCT02352480
withdrawnphase_4
Effectiveness of Aurix Therapy in Venous Leg Ulcers
NCT02940587
Clinical Trials (4)
Showing 4 of 4 trials
NCT02352454Not Applicable
Effectiveness of Aurix Therapy in Venous Leg Ulcers
NCT02352467Not Applicable
Effectiveness of Aurix Therapy in Pressure Ulcers
NCT02352480Not Applicable
Effectiveness of Aurix Therapy in Diabetic Foot Ulcers
NCT02940587Phase 4
Effectiveness of Aurix Therapy in Venous Leg Ulcers
All 4 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 4